Public availability of results of observational studies evaluating an intervention registered at ClinicalTrials.gov

BMC Medicine
Marie BaudartIsabelle Boutron

Abstract

Observational studies are essential for assessing safety. The aims of this study were to evaluate whether results of observational studies evaluating an intervention with safety outcome(s) registered at ClinicalTrials.gov were published and, if not, whether they were available through posting on ClinicalTrials.gov or the sponsor website. We identified a cohort of observational studies with safety outcome(s) registered on ClinicalTrials.gov after October 1, 2007, and completed between October 1, 2007, and December 31, 2011. We systematically searched PubMed for a publication, as well as ClinicalTrials.gov and the sponsor website for results. The main outcomes were the time to the first publication in journals and to the first public availability of the study results (i.e. published or posted on ClinicalTrials.gov or the sponsor website). For all studies with results publicly available, we evaluated the completeness of reporting (i.e. reported with the number of events per arm) of safety outcomes. We identified 489 studies; 334 (68%) were partially or completely funded by industry. Results for only 189 (39%, i.e. 65% of the total target number of participants) were published at least 30 months after the study completion. When sea...Continue Reading

References

Jan 15, 1992·JAMA : the Journal of the American Medical Association·K DickersinC L Meinert
May 11, 1996·BMJ : British Medical Journal·N Black
May 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Monika K KrzyzanowskaIan F Tannock
Sep 10, 2004·JAMA : the Journal of the American Medical Association·Catherine D DeAngelisUNKNOWN International Committee of Medical Journal Editors
Sep 15, 2004·Lancet·Catherine De AngelisUNKNOWN International Committee of Medical Journal Editors
Jan 18, 2008·The New England Journal of Medicine·Erick H TurnerRobert Rosenthal
Mar 8, 2008·Science·Deborah A Zarin, Tony Tse
Aug 30, 2008·JAMA : the Journal of the American Medical Association·Bruce M Psaty, Jan P Vandenbroucke
Jul 22, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher M BoothRalph M Meyer
Sep 3, 2009·JAMA : the Journal of the American Medical Association·Sylvain MathieuPhilippe Ravaud
Nov 11, 2009·PLoS Medicine·Joseph S RossHarlan M Krumholz
Feb 20, 2010·BMJ : British Medical Journal·Elizabeth LoderDomhnall Macauley
Feb 26, 2010·Health Technology Assessment : HTA·F SongI Harvey
Jul 21, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Rebecca J WilliamsDeborah A Zarin
Dec 14, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ralph M Meyer
Jan 5, 2012·BMJ : British Medical Journal·Beth HartLisa Bero
Jan 5, 2012·BMJ : British Medical Journal·Joseph S RossHarlan M Krumholz
Aug 9, 2012·JAMA : the Journal of the American Medical Association·John P A Ioannidis
Jul 24, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thi-Anh-Hoa NguyenPhilippe Ravaud
Jan 15, 2014·Lancet·An-Wen ChanH Bart van der Worp
Feb 21, 2014·Science Translational Medicine·Rafael Dal-RéElisabete Weiderpass
Apr 2, 2014·Annals of Internal Medicine·Daniel M HartungMark Helfand
Aug 27, 2014·PLoS Medicine·UNKNOWN PLOS Medicine Editors
Aug 19, 2015·Journal of Clinical Epidemiology·Christopher W HalladayIssa J Dahabreh

❮ Previous
Next ❯

Citations

Feb 28, 2017·Journal of Clinical Epidemiology·Seung Yeon SongEun Young Kim
Mar 28, 2017·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·A HenryA W Welsh
Feb 28, 2019·Neurosurgery·Herschel W WildeJohn D Rolston
Mar 24, 2016·BMC Medical Research Methodology·Timor FaberAgnes Dechartres
May 29, 2018·Therapeutic Innovation & Regulatory Science·Issis Kelly-Pumarol, Joseph E Andrews
May 11, 2021·British Journal of Clinical Pharmacology·Jan Borysowski, Andrzej Górski

❮ Previous
Next ❯

Software Mentioned

R
Embase

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.